- Home
- CALC vs NDLS Comparison
CALC vs NDLS Comparison
Compare CALC & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CALC | NDLS |
|---|---|---|
| Founded | 2011 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.0M | 29.8M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | CALC | NDLS |
|---|---|---|
| Price | $4.88 | $0.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | 135.7K | ★ 707.8K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $494,087,000.00 |
| Revenue This Year | N/A | $2.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.42 | $0.55 |
| 52 Week High | $5.34 | $1.74 |
Technical Indicators
Market Signals| Indicator | CALC | NDLS |
|---|---|---|
| Relative Strength Index (RSI) | 64.91 | 39.85 |
| Support Level | $4.24 | $0.60 |
| Resistance Level | $5.34 | $0.80 |
| Average True Range (ATR) | 0.42 | 0.12 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 66.80 | 7.14 |
Price Performance
Historical ComparisonAbout CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.